| Natural history and risk stratification in Andersen-Tawil syndrome type 1 A Mazzanti, D Guz, A Trancuccio, E Pagan, D Kukavica, T Chargeishvili, ... Journal of the American College of Cardiology 75 (15), 1772-1784, 2020 | 52 | 2020 |
| Acute myocarditis associated with desmosomal gene variants E Ammirati, F Raimondi, N Piriou, L Sardo Infirri, SA Mohiddin, A Mazzanti, ... Heart Failure 10 (10), 714-727, 2022 | 50 | 2022 |
| Association of hydroxychloroquine with QTc interval in patients with COVID-19 A Mazzanti, M Briani, D Kukavica, F Bulian, S Marelli, A Trancuccio, ... Circulation 142 (5), 513-515, 2020 | 44 | 2020 |
| Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 SG Priori, A Mazzanti, DJ Santiago, D Kukavica, A Trancuccio, JC Kovacic Journal of the American College of Cardiology 77 (20), 2592-2612, 2021 | 41 | 2021 |
| Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) A Mazzanti, A Trancuccio, D Kukavica, E Pagan, M Wang, M Mohsin, ... EP Europace 24 (4), 614-619, 2022 | 40 | 2022 |
| Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator P Jordà, LP Bosman, A Gasperetti, A Mazzanti, JB Gourraud, B Davies, ... European heart journal 43 (32), 3041-3052, 2022 | 37 | 2022 |
| Outcomes of patients with catecholaminergic polymorphic ventricular tachycardia treated with β-blockers A Mazzanti, D Kukavica, A Trancuccio, M Memmi, R Bloise, P Gambelli, ... JAMA cardiology 7 (5), 504-512, 2022 | 31 | 2022 |
| Arrhythmic mitral valve prolapse: introducing an era of multimodality imaging-based diagnosis and risk stratification D Kukavica, M Guglielmo, A Baggiano, G Muscogiuri, L Fusini, M Muratori, ... Diagnostics 11 (3), 467, 2021 | 22 | 2021 |
| Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment—Authors' reply A Mazzanti, A Trancuccio, D Kukavica, E Pagan, M Wang, M Mohsin, ... EP Europace 24 (4), 698-699, 2022 | 4 | 2022 |
| Is mexiletine ready for prime time in patients with Type 2 Long QT Syndrome? A Mazzanti, T Chargeishvili, D Kukavica, M Marino, M Morini, ... European Heart Journal 41 (Supplement_2), ehaa946. 0750, 2020 | 3 | 2020 |
| Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe RT Carrick, C De Marco, A Gasperetti, LP Bosman, JB Gourraud, ... European Heart Journal 45 (7), 538-548, 2024 | 2 | 2024 |
| Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? D Kukavica, A Trancuccio, C Arno, AC Latini, A Mazzanti, SG Priori Minerva Cardiology and Angiology 70 (2), 217-237, 2021 | 2 | 2021 |
| Unexpected impairment of INa underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome A Porta-Sánchez, A Mazzanti, C Tarifa, D Kukavica, A Trancuccio, ... Nature Publishing Group, 2023 | 1 | 2023 |
| Molecular Insights into the Rescue Mechanism of an hERG Activator Against Severe LQT2 Mutations. A Kumawat, E Tavazzani, G Lentini, A Trancuccio, D Kukavica, M Denegri, ... bioRxiv, 2024.03. 13.584147, 2024 | | 2024 |
| Computational Modeling of Cardiac Electrophysiology Applied to a Swine Model of Long QT Syndrome A Trancuccio Università degli studi di Pavia, 2023 | | 2023 |
| Unexpected impairment of INa underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome A Porta-Sánchez, A Mazzanti, C Tarifa, D Kukavica, A Trancuccio, ... Nature Cardiovascular Research 2 (12), 1291-1309, 2023 | | 2023 |
| Overexpression of cardiac calsequestrin as a novel gene-therapy approach to treat CPVT1: in silico and in vivo proves of principle D Santiago Castillo, R Bongianino, A Trancuccio, D Kukavica, C Tarifa, ... European Heart Journal 44 (Supplement_2), ehad655. 3135, 2023 | | 2023 |
| Unexpectedly high prevalence of structural genomic variations in the Long QT Syndrome: evidence for broader clinical uptake A Mazzanti, M Memmi, P Gambelli, A Guarracino, B Colombi, J Nastoli, ... European Heart Journal 44 (Supplement_2), ehad655. 626, 2023 | | 2023 |
| Artificial intelligence-driven echocardiographic classification identifies Brugada Syndrome patients at higher arrhythmic risk D Kukavica, A Trancuccio, A Esposito, M Marino, R Bloise, C Napolitano, ... European Heart Journal 44 (Supplement_2), ehad655. 244, 2023 | | 2023 |
| Implantable loop recorder monitoring in inherited cardiomyopathies: yield of clinically relevant arrhythmias A Trancuccio, D Kukavica, G Zvielli, M Marino, P Gambelli, M Memmi, ... European Heart Journal 44 (Supplement_2), ehad655. 310, 2023 | | 2023 |
Silvia G Priori, MD ,PhDICS Maugeri, IRCCS; Dept Molecular Medicine, Univ of Pavia, Italy -Verified email at fsm.it
